A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasma

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 494-497

  Moody, David E ^a   Laycock, John D ^a,b   Huang, Wei ^a   Foltz, Rodger L ^a  

^a UNIVERSITY OF UTAH   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALIPERIDONE; RISPERIDONE;

ANALYTIC METHOD; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MENTAL DISEASE; PLASMA; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TANDEM MASS SPECTROMETRY;

EID: 4344696606     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.494     Document Type: Conference Paper

References (19)

1. J.E. Leysen, W. Gommeren, A. Eens, D. de Chaffoy de Courcelles, J.C. Stoof, and P.A.J. Janssen. Biochemical profile of risperidone, a new antipsychotic. J. Pharmacol. Exp. Ther. 247: 661-670 (1988).
2. A. Schotte, P.F.M. Janssen, W. Gommeren, W.H.M.L Luyten, P. Van Gompel, A.S. Lesage, K. De Loore, and J.E. Leysen. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124: 57-73 (1996).
3. S. Grant and A. Fitton. Risperidone: a review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs 48: 253-273 (1994).
4. G. Mannens, M.-L. Huang, W. Meuldermans, J. Hendrickx, R. Woestenborghs, and J. Heykants. Absorption, metabolism, and excretion of risperidone in humans. Drug Metab. Dispos. 21: 1134-1141 (1993).
5. J. Fang, M. Bourin, and G.B. Baker. Metabolism or risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. N-S. Arch. Pharmacol. 359: 147-151 (1999).
6. M.-L. Huang, A. Van Peer, R. Woestenborghs, R. De Coster, J. Heykants, A.A.I. Jansen, Z. Zylicz, H.W. Visscher, and J.H.G. Jonkman. Pharmacokinetics of the novel antipsychotic agent risperidone and its prolactin response in healthy subjects. Clin. Pharmacol. Ther. 54: 257-268 (1993).
7. J.A. Bork, T. Rogers, P.J. Wedlund, and J. de Leon. A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A. J. Clin. Psychiatry 60: 469-476 (1999).
8. P. Odou, J.C. Levron, M. Luyckx, C. Brunet, and H. Robert. Risperidone drug monitoring-a useful clinical tool? Clin. Drug Invest. 19: 283-292 (2000).
9. M.G. Scordo, E. Spina, P. Romeo, M.-L. Dahl, L. Bertilsson, I. Johansson, and F. Sjoqvist. CYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients. Eur. J. Clin. Pharmacol. 56: 679-683 (2000).
10. R. Woestenborghs, W. Lorreyne, F. Van Rompaey, and J. Heykants. Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography. J. Chromatogr. 583: 223-230 (1992).
11. O.V. Olesen and K. Linnet. Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other drugs. J. Chromatogr. B 698: 209-216 (1997).
12. M. Aravagiri, S.R. Marder, T. Van Putten, and K.K. Midha. Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to the therapeutic drug monitoring in schizophrenic patients. J. Pharm. Sci. 82: 447-449 (1993).
13. J.P. Le Moing, S. Edouard, and J.C. Levron. Determinaton of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 614: 333-339 (1993).
14. A.E. Balant-Gorgia, M. Gex-Fabry, C. Genet, and L.P. Balant. Therapeutic drug monitoring of risperidone using a new rapid HPLC method: reappraisal of interindividual variability factors. Ther. Drug Monit. 21: 105-115 (1999).
15. D.S. Schatz and A. Saria. Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma with high-performance liquid chromatography with coulometric detection. Pharmacology 60: 51-56 (2000).
16. H.H. Maurer, T. Kraemer, C. Kratzsch, F.T. Peters, and A.A. Weber. Negative ion chemical ionization gas chromatography-mass spectrometry and atmospheric pressure chemical ionization liquid chromatography-mass spectrometry of low-dose and/or polar drugs in plasma. Ther. Drug Monit. 24: 117-124 (2002).
17. M. Aravagiri and S.R. Marder. Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry. J. Mass Spectrom. 35: 718-724 (2000).
18. S.-N. Lin, D.E. Moody, G.E. Bigelow, and R.L. Foltz. A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma. J. Anal. Toxicol. 25: 497-503 (2001).
19. C. Kratzsch, F.T. Peters, T. Kraemer, A.A. Weber, and H.H. Maurer. Screening, library-assisted identification and validated quantitation of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 38: 283-295 (2003).